IRIS

CIFALDI, LOREDANA CONCETTA

CIFALDI, LOREDANA CONCETTA  

Dipartimento di Scienze cliniche e Medicina Traslazionale  

Mostra records
Risultati 1 - 20 di 53 (tempo di esecuzione: 0.02 secondi).
Data di pubblicazione Titolo Autore(i) Tipo File
1-apr-2001 A light, nontoxic interleukin 12 protocol inhibits HER-2/neu mammary carcinogenesis in BALB/c transgenic mice with established hyperplasia Cifaldi, L; Quaglino, E; Di Carlo, E; Musiani, P; Spadaro, M; Lollini, P; Wolf, S; Boggio, K; Forni, G; Cavallo, F Articolo su rivista
1-feb-2013 ADAR2-editing activity inhibits glioblastoma growth through the modulation of the CDC14B/Skp2/p21/p27 axis Galeano, F; Rossetti, C; Tomaselli, S; Cifaldi, L; Lezzerini, M; Pezzullo, M; Boldrini, R; Massimi, L; Di Rocco, C; Locatelli, F; Gallo, A Articolo su rivista
1-mag-2008 Antagomir-17-5p abolishes the growth of therapy-resistant neuroblastoma through p21 and BIM Fontana, L; Fiori, M; Albini, S; Cifaldi, L; Giovinazzi, S; Forloni, M; Boldrini, R; Donfrancesco, A; Federici, V; Giacomini, P; Peschle, C; Fruci, D Articolo su rivista
1-gen-2024 Bisphenol-A in Drinking Water Accelerates Mammary Cancerogenesis and Favors an Immunosuppressive Tumor Microenvironment in BALB-neu T Mice Focaccetti, C; Nardozi, D; Benvenuto, M; Lucarini, V; Angiolini, V; Carrano, R; Scimeca, M; Servadei, F; Mauriello, A; Mancini, P; Mersini Besharat, Z; Milella, M; Migliaccio, S; Ferretti, E; Cifaldi, L; Masuelli, L; Palumbo, C; Bei, R Articolo su rivista
1-dic-2017 Boosting Natural Killer Cell-Based Immunotherapy with Anticancer Drugs: a Perspective Cifaldi, L; Locatelli, F; Marasco, E; Moretta, L; Pistoia, V Articolo su rivista
1-gen-2010 CD56highCD16-CD62L- NK cells accumulate in allergic contact dermatitis and contribute to the expression of allergic responses Carbone, T; Nasorri, F; Pennino, D; Eyerich, K; Foerster, S; Cifaldi, L; Traidl-Hoffman, C; Behrendt, H; Cavani, A Articolo su rivista
1-nov-2020 Cellular and gene signatures of tumor-infiltrating dendritic cells and natural-killer cells predict prognosis of neuroblastoma Melaiu, O; Chierici, M; Lucarini, V; Jurman, G; Conti, L; De Vito, R; Boldrini, R; Cifaldi, L; Castellano, A; Furlanello, C; Barnaba, V; Locatelli, F; Fruci, D Articolo su rivista
14-mag-2024 Characterization of Natural Killer Cell Profile in a Cohort of Infected Pregnant Women and Their Babies and Its Relation to CMV Transmission Pighi, C; Rotili, A; De Luca, M; Chiurchiù, S; Calò Carducci, Fi; Rossetti, C; Cifaldi, L; Bei, R; Caforio, L; Bernardi, S; Palma, P; Amodio, D Articolo su rivista
1-feb-2009 Chronic eczema in a patient with Leukocyte Adhesion Deficiency (LAD) type I Eyerich, K; Cifaldi, L; Notarangelo, L; Porta, F; Notarangelo, L; Mazzolari, E; Fiorini, M; Paradisi, A; Cavani, A Articolo su rivista
1-gen-2022 Combined treatment with inhibitors of ErbB Receptors and Hh signaling pathways is more effective than single treatment in reducing the growth of malignant mesothelioma both in vitro and in vivo Bei, R; Benvenuto, M; Focaccetti, C; Fazi, S; Moretti, M; Nardozi, D; Angiolini, V; Ciuffa, S; Cifaldi, L; Carrano, R; Palumbo, C; Miele, Mt; Bei, R; Barillari, G; Manzari, V; De Smaele, E; Modesti, A; Masuelli, L Articolo su rivista
1-gen-2023 Curcumin potentiates the ErbB receptors inhibitor Afatinib for enhanced antitumor activity in malignant mesothelioma Benvenuto, M; Nardozi, D; Palumbo, C; Focaccetti, C; Carrano, R; Angiolini, V; Cifaldi, L; Lucarini, V; Mancini, P; Kerpi, B; Currenti, W; Bei, R; Masuelli, L Articolo su rivista
21-feb-2024 Dietary Polyphenols Effects on Focal Adhesion Plaques and Metalloproteinases in Cancer Invasiveness Carrano, R; Grande, M; LETI MAGGIO, E; Zucca, C; Bei, R; Palumbo, C; Focaccetti, C; Nardozi, D; Lucarini, V; Angiolini, V; Mancini, P; Barberini, F; Barillari, G; Cifaldi, L; Masuelli, L; Benvenuto, M; Bei, R Articolo su rivista
2-feb-2023 Different outcome of targeting ERN1/IRE1 alpha and EIF2AK3/PERK in NSG mice engrafted with primary effusion lymphoma Arena, A; Romeo Maria, A; Focaccetti, C; Anastasiadou, E; Trived, P; Cifaldi, L; Gilardini, M; Maria, S; Benedetti, R; Santarelli, R; Gonnella, R; Benvenuto, M; Marchese, C; Masuelli, L; Bei, R; Cirone, M Articolo su rivista
1-lug-2019 DNAM-1 Activating Receptor and Its Ligands: How Do Viruses Affect the NK Cell-Mediated Immune Surveillance during the Various Phases of Infection? Cifaldi, L; Doria, M; Cotugno, N; Zicari, S; Cancrini, C; Palma, P; Rossi, P Articolo su rivista
1-giu-2023 DNAM-1 chimeric receptor-engineered NK cells: a new frontier for CAR-NK cell-based immunotherapy Cifaldi, L; Melaiu, O; Giovannoni, R; Benvenuto, M; Focaccetti, C; Nardozi, D; Barillari, G; Bei, R Articolo su rivista
28-lug-2022 DNAM-1-chimeric receptor-engineered NK cells, combined with Nutlin-3a, more effectively fight neuroblastoma cells in vitro: a proof-of-concept study. Focaccetti, C; Benvenuto, M; Pighi, C; Vitelli, A; Napolitano, F; Cotugno, N; Fruci, D; Palma, P; Rossi, P; Bei, R; Cifaldi, L Articolo su rivista
1-giu-2020 Editorial: Molecular Strategies Aimed to Boost NK Cell-Based Immunotherapy of Cancer Cifaldi, L; Di Santo, J; Olive, D Articolo su rivista
1-gen-2021 Enhancement of neuroblastoma NK-cell-mediated lysis through NF-kB p65 subunit-induced expression of FAS and PVR, the loss of which is associated with poor patient outcome Brandetti, E; Focaccetti, C; Pezzolo, A; Ognibene, M; Folgiero, V; Cotugno, N; Benvenuto, M; Palma, P; Manzari, V; Rossi, P; Fruci, D; Bei, R; Cifaldi, L Articolo su rivista
1-gen-2012 ERAAP modulation: A possible novel strategy for cancer immunotherapy? Fruci, D; Locatelli, F; Cifaldi, L Articolo su rivista
1-gen-2021 ERAP1 controls the interaction of the inhibitory receptor KIR3DL1 with HLA-B51:01 by affecting natural killer cell function D'Amico, S; D'Alicandro, V; Compagnone, M; Tempora, P; Guida, G; Romania, P; Lucarini, V; Melaiu, O; Falco, M; Algeri, M; Pende, D; Cifaldi, L; Fruci, D Articolo su rivista